" Skip to main content

Iovance Biotherapeutics – Cell Therapy Center

Project Name: Iovance Biotherapeutics – Cell Therapy Center
Location: 300 Rouse Blvd, Navy Yard Corporate Center
Market: Life Science / Biotechnology
Application: Building Heat, Humidification
Mechanical Engineer:  CRB
Mechanical Contractor: A.T. Chadwick Co., Inc.


  • Two Fulton Endura+ Model EDR+6000 Condensing Boilers
  • One Fulton Engineered Steam Skid, which includes:
    • One Vertical Spiral Rib Tubeless Model VSRT-50 Steam Boilers
    • Room for (2) Future 50HP Steam Boilers
    • One Fulton Horizontal Boiler Feed Model HT-100 Duplex Boiler Feed
    • One Fulton Blowdown Model F-75
    • One Fulton Deluxe Chemical Feed w/ Agitator
Download PDF

Iovance Biotherapeutics Inc., a California based cancer-therapy firm, is opening a 136,000 sq/ft office and laboratory complex is Philadelphia’s Navy Yard. Iovance will use the facility to manufacture its tumor-infiltrating lymphocyte (TIL)-based treatments, which use patients own cancer inflicted cells to produce personalized therapies. Philadelphia was chosen in part because of its deep talent pool and adds to the cities growing clout as a biotechnology research-and-development hub. Iovance plans to employ several hundred at the Navy Yard facility and will produce treatments for thousands of patients around the world.

UEP Northeast provided (2) Fulton Endura Plus 6000 MBH high efficiency condensing boilers that will provide building heat. Additionally, the facility’s steam requirements, specifically humidification, are being served by a Fulton Engineered Skid package, which includes (3) VSRT 50 HP steam boilers (one now, two future), boiler feed systems, blowdown separator, water treatment and controls furnished.  The UEP Northeast team worked very closely on the design with the projects mechanical engineer, CRB, and during the install phase with the project’s mechanical contactor, AT Chadwick Co.

UEP Northeast is excited about Philadelphia’s significant growth in its life sciences sector. Over the past several years, the region has emerged as a center of excellence in emerging cell and gene therapies. With our experience and technical staff, as well as the type manufacturers we represent, we are uniquely suited to serve this industry.